Egypt has officially undertaken a comprehensive overhaul of its decades-old pharmaceutical pricing framework, a decisive policy shift designed to resolve…
Read More
The Hidden Costs of Supplier Sprawl: Why Pharmaceutical Supply Chains Are Moving Toward Consolidation
For decades, the standard playbook for pharmaceutical procurement departments was built on the premise of diversification. As companies launched new…
Read More
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
The landscape of neuropsychiatric care has reached a significant milestone following the United States Food and Drug Administration (FDA) approval…
Read More
Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia
The global biopharmaceutical landscape witnessed a significant strategic alliance as Biohaven Ltd. announced a landmark licensing and regional partnership agreement…
Read More
KymaThera pulls in $80m to bring breast cancer drug to clinic – Pharmaceutical Technology
San Diego-based biopharmaceutical company KymaThera has successfully closed an $80 million Series B financing round to propel its lead oncology…
Read More
Bayer Commits $2.2bn to Establish State-of-the-Art Pharmaceutical Manufacturing Facility at New Albany International Business Park in Ohio
Life sciences giant Bayer has announced a monumental $2.2bn capital investment dedicated to the construction of a cutting-edge pharmaceutical manufacturing…
Read More
BioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery Collaboration
In a significant move bridging artificial intelligence and biotechnology, BioMarin Pharmaceutical has forged a strategic research collaboration with Emeryville-based tech…
Read More
Varda Space Industries Secures $251m in Series D Funding to Pioneer Commercial In-Space Pharmaceutical Manufacturing
Varda Space Industries has successfully closed a massive $251m Series D financing round, bringing its cumulative venture backing to $598m…
Read More
Beyond OEB6: The Complex Evolution of High-Potency Containment in Modern Pharmaceutical Manufacturing
Few areas of pharmaceutical manufacturing have attracted as much capital investment, strategic realignment, and engineering ingenuity in recent years as…
Read More
DFE Pharma Expands Continuous Manufacturing Capabilities to Address Industry-Wide Adoption Challenges in Pharmaceutical Production
The global pharmaceutical manufacturing sector is undergoing a profound paradigm shift, moving steadily away from traditional batch processing toward continuous…
Read More
